STAT

Seeking reform, a neuroscientist argues against ‘sexist’ beliefs that keep research focused on male animals

A neurobiologist is arguing that outdated gender stereotypes, many of which are not evidence-based, are still finding their way into scientific experiments.

Starting in 2016, the National Institutes of Health mandated that researchers applying for grants factor sex as a variable into experiment design and data analyses. But one neurobiologist argues that outdated gender stereotypes, many of which are not evidence-based, are still finding their way into scientific experiments.

In a perspective published Thursday in Science, Northeastern University neurobiologist Rebecca Shansky said that one of the biggest misconceptions among her colleagues and many male and female scientists is that female hormones — and the estrous cycle in mice, which corresponds to the menstrual cycle in women — are “messy” and complicate matters for research.

“It seems that we are applying all of these higher standards for rigor to female animals that we haven’t had for male animals, and it’s all essentially based around this idea of ovarian hormones, and that to me just seems really wrong.”

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related